肝纤维化的发病机理及相关信号转导机制研究进展
作者:
作者单位:

1.合肥市第二人民医院(安徽医科大学附属合肥医院)药学部,合肥 230011;2.凤阳县人民医院,普外科,安徽 滁州 233100

中图分类号:

R-33


Research progress on the pathogenesis and related signal transduction mechanisms of liver fibrosis
Author:
Affiliation:

1. Department of Pharmacy, the Second People’s Hospital of Hefei (Hefei Hospital of Anhui Medical University), Hefei 230011, China. 2. Department of General Surgery, People’s Hospital of Fengyang County, Chuzhou 233100

  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • | |
  • 文章评论
    摘要:

    肝硬化是由各种原因导致的肝细胞外基质过度增生与分解的失衡所致的疾病,是多种肝疾病向肝硬化发展的关键环节。肝纤维化的发生过程是可逆的,主要是肝损伤导致肝星状细胞活化后形成肌纤维细胞,过度沉积在肝内,进而发生肝纤维化,其后果常导致不可逆的肝硬化甚至肝癌的发生。目前对于肝纤维化的具体发病机理及相关分子信号转导机制尚不明确。因此,深入探索肝纤维化的发病机制对抗肝纤维化靶点药物研究具有重要意义,为此,本文主要基于国内外相关文献,结合近年来有关肝纤维化的发病机理及相关信号转导研究作一综述。

    Abstract:

    Cirrhosis is caused by an imbalance of hyperplasia and extracellular matrix decomposition in the liver for various reasons, and it is a major link between various liver diseases to the development of cirrhosis. The process of liver fibrosis is reversible. Liver injury leads to activation of hepatic stellate cells to form muscle fibrocytes, excessive extracellular matrix deposition in the liver, and then liver fibrosis. Its consequences often lead to irreversible cirrhosis and even liver cancer. The specific pathogenesis and molecular signal transduction mechanism of liver fibrosis are unclear. Therefore, it is important to explore the pathogenesis of hepatic fibrosis and investigate anti-fibrotic target drugs. To this end, this article reviews the pathogenesis of liver fibrosis and the related signal transduction studies.

    参考文献
    相似文献
    引证文献
引用本文

李明芳,李曹飞,左东泽,赵营莉,余士贝,谢耀辉,彭家志,刘建军.肝纤维化的发病机理及相关信号转导机制研究进展[J].中国比较医学杂志,2023,33(8):147~152.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2022-11-18
  • 在线发布日期: 2023-11-09
防诈骗提示!请勿点击不明链接或添加个人微信。编辑部所有邮箱后缀均为@cnilas.org
关闭